4D Molecular Therapeutics, Inc 10-Q for FY2026 Q2
4D Molecular Therapeutics, Inc. (FDMT)
10-Q
2026-08-13
For: 2026-06-30
View Original
Added on
August 13, 2026
About this 10-Q
4D Molecular Therapeutics, Inc filed this 10-Q on August 13, 2026, covering the quarter ended June 30, 2026 (FY2026 Q2).
Headline figures
Quarter ended June 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $3.78M
- up 25106.7% from $15K a year earlier
- Net loss
- $72.94M
- compared with a net loss of $54.66M a year earlier
- Diluted EPS
- -$1.04
- compared with -$0.98 a year earlier